Taggart R T, Samloff I M
Science. 1983 Mar 11;219(4589):1228-30. doi: 10.1126/science.6402815.
A method is described for obtaining antibody-producing hybridomas that are preferentially retained in cultures of fused mouse spleen and myeloma cells. Hybridomas are produced by fusing mouse myeloma cells that are deficient in adenosine phosphoribosyltransferase (APRT) with mouse spleen cells containing Robertsonian 8.12 translocation chromosomes. The cell fusion mixtures are exposed to a culture medium that can be utilized only by APRT-positive cells, which results in the elimination of both unfused APRT-deficient myeloma cells and non-antibody-producing APRT-deficient hybridomas that arise by segregation of the 8.12 translocation chromosomes containing the APRT genes and the active heavy chain immunoglobulin gene.
本文描述了一种获得能优先保留在融合的小鼠脾脏细胞和骨髓瘤细胞培养物中的产抗体杂交瘤的方法。杂交瘤是通过将缺乏腺苷磷酸核糖转移酶(APRT)的小鼠骨髓瘤细胞与含有罗伯逊8.12易位染色体的小鼠脾脏细胞融合而产生的。将细胞融合混合物暴露于仅能被APRT阳性细胞利用的培养基中,这导致未融合的APRT缺陷型骨髓瘤细胞和由含有APRT基因和活性重链免疫球蛋白基因的8.12易位染色体分离产生的不产生抗体的APRT缺陷型杂交瘤均被消除。